Keeping our adult patients healthy and active: the role of vaccines across the lifespan
- PMID: 21150140
- DOI: 10.3810/psm.2010.12.1823
Keeping our adult patients healthy and active: the role of vaccines across the lifespan
Abstract
The Centers for Disease Control and Prevention (CDC) recommend vaccinations from birth through adulthood for lifetime protection against many diseases and infections. Healthy, active adults need to be vaccinated for personal protection against infection as well as associated health benefits (eg, ability to maintain their daily activities). Immunization also reduces the risk of an individual transmitting infection to others, thereby conferring protection to his or her entire community. In the United States, influenza and pertussis (part of the trivalent Tdap) vaccines are recommended for every adult. There are other important vaccines for adults: the human papillomavirus (HPV) vaccine is recommended for every adult female aged up to 26 years, shingles vaccine is recommended for all adults aged ≥ 60 years, and pneumococcal vaccine is recommended based on age (all adults aged ≥ 65 years) and risk factors. Hepatitis A, hepatitis B, and meningococcal vaccines are recommended for adults with certain risk factors or conditions that increase their risk for serious complications (ie, there are no age-based recommendations for these vaccines in adults). Catch-up vaccination is also recommended for adults who have no evidence or proof of immunity to selected, traditionally childhood infections (ie, measles, mumps, rubella, and varicella). Despite the established safety and efficacy of vaccines for disease prevention, millions of adults who should be vaccinated are not, resulting in substantial and avoidable morbidity and mortality, as well as health care expenditures. It is incumbent on health care providers to raise awareness among their adult patients and encourage vaccination, thereby improving uptake among eligible adults. Routine vaccination into adulthood must be viewed as standard of care and an integral component of a comprehensive preventive care program.
Similar articles
-
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.Clin Infect Dis. 2009 Sep 15;49(6):817-40. doi: 10.1086/605430. Clin Infect Dis. 2009. PMID: 19659433
-
[Adult immunization in France: an update].Rev Prat. 2004 Mar 15;54(5):499-505. Rev Prat. 2004. PMID: 15176507 Review. French.
-
[Adult immunization].Bull Acad Natl Med. 2003;187(8):1463-74; discussion 1474-6. Bull Acad Natl Med. 2003. PMID: 15146578 Review. French.
-
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759. Pediatrics. 2005. PMID: 16061582
-
[Vaccinations: the necessary and the desirable].Schweiz Med Wochenschr. 1997 Mar 8;127(10):377-81. Schweiz Med Wochenschr. 1997. PMID: 9132924 Review. German.
Cited by
-
Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19.ACS Pharmacol Transl Sci. 2020 Aug 27;3(5):790-800. doi: 10.1021/acsptsci.0c00071. eCollection 2020 Oct 9. ACS Pharmacol Transl Sci. 2020. PMID: 33062949 Free PMC article. Review.
-
Assessment of vaccine candidates for persons aged 50 and older: a review.BMC Geriatr. 2013 Apr 15;13:32. doi: 10.1186/1471-2318-13-32. BMC Geriatr. 2013. PMID: 23586926 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical